INFINITOPES LIMITED

Active Oxford

Research and experimental development on biotechnology

18 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
I

INFINITOPES LIMITED

Research and experimental development on biotechnology

Founded 24 Sept 2021 Active Oxford, England 18 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 3 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 29 Sept 2025 Next due 7 Oct 2026 5 months remaining
Net assets £9M £1M 2023 year on year
Total assets £10M £1M 2023 year on year
Total Liabilities £154K £42K 2023 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Bioescalator Innovation Building Oxford University 696 Roosevelt Drive Oxford OX3 7FZ England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for INFINITOPES LIMITED (13642685), an active life sciences and medical technology company based in Oxford, England. Incorporated 24 Sept 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2022–2023)

Cash in Bank

£9.01M

Increased by £1.12M (+14%)

Net Assets

£9.35M

Increased by £1.28M (+16%)

Total Liabilities

£153.82k

Decreased by £42.13k (-22%)

Turnover

N/A

Employees

18

Increased by 12 (+200%)

Debt Ratio

2%

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

6 Allotments 20,400,379 Shares £21.56m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
19 Dec 202516,076,311£8.20m£0.51
30 Nov 2023960,974£3.94m£4.1
15 Jun 2023619,411£24.776£0
9 Dec 20221,945,360£7.98m£4.1
9 Dec 2022698,323£1.25m£1.79

Officers

Officers

1 active 2 resigned
Status
Lian Ni LeeDirectorMalaysianEngland5124 Sept 2021Active

Shareholders

Shareholders (37)

Senthil Kumar Chinnakannan
13.5%
1,000,000
Lian Ni Lee
13.5%
1,000,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Jonathan Kwok

Ceased 6 Dec 2022

Ceased

Senthil Kumar Chinnakannan

Ceased 6 Dec 2022

Ceased

Lian Ni Lee

Ceased 6 Dec 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Feb 2026CapitalAllotment of shares (GBP 939.51516) on 2026-01-28
7 Jan 2026ResolutionResolutions
7 Jan 2026IncorporationMemorandum Articles
5 Jan 2026OfficersAppointment of Dr Elliot Hershberg as director on 2025-12-19
31 Dec 2025OfficersChange Person Secretary Company With Change Date
3 Feb 2026 Capital

Allotment of shares (GBP 939.51516) on 2026-01-28

7 Jan 2026 Resolution

Resolutions

7 Jan 2026 Incorporation

Memorandum Articles

5 Jan 2026 Officers

Appointment of Dr Elliot Hershberg as director on 2025-12-19

31 Dec 2025 Officers

Change Person Secretary Company With Change Date

Recent Activity

Latest Activity

Allotment of shares (GBP 939.51516) on 2026-01-28

2 months ago on 3 Feb 2026

Resolutions

3 months ago on 7 Jan 2026

Memorandum Articles

3 months ago on 7 Jan 2026

Appointment of Dr Elliot Hershberg as director on 2025-12-19

3 months ago on 5 Jan 2026

Change Person Secretary Company With Change Date

3 months ago on 31 Dec 2025